This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220. This website reflects only the author’s view and the Commission is not responsible for any use that may be made of the information it contains.

Second RWE-AI IG Quarterly Meeting 

The importance of Real World Evidence (RWE) in Health Technology Assessment (HTA) is increasing over time, as technological advances have given rise to innovative tools for collecting and recording information, and for generating and synthesizing evidence from a  wide variety of settings in the real world, and oftentimes, even, in real time. Additionally, stakeholders have a better understanding of how access to innovative technologies can be facilitated and even accelerated. They are willing and even eager to consider the use of machine learning (ML) and artificial intelligence (AI) technologies to gain the advantage of more comprehensive evidence to inform decision-making.

Access to the website

Access to the recording:


Jul 08 2021